about
The effect of activated protein C on experimental acute necrotizing pancreatitisCorrection: The effect of activated protein C on experimental acute necrotizing pancreatitisInflammation and frailty in the elderly: A systematic review and meta-analysisCombination of allopurinol and hyperbaric oxygen therapy: a new treatment in experimental acute necrotizing pancreatitis?The volume prediction on the experimental design hippocampus using stereological method.Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat modelWhich is preferable for orthostatic hypotension diagnosis in older adults: active standing test or head-up tilt table test?Oxidative stress and frailty: A systematic review and synthesis of the best evidence.Hypovitaminosis D and orthostatic hypotension: a systematic review and meta-analysis.Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: a systematic review and meta-analysis.When should orthostatic blood pressure changes be evaluated in elderly: 1st, 3rd or 5th minute?Effects of Acetylcholinesterase Inhibitors on Nutritional Status in Elderly Patients with Dementia: A 6-month Follow-up Study.Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.Vitamin B12 and folic acid levels are not related to length of stay in elderly inpatients.COST: Cognitive State Test, a brief screening battery for Alzheimer disease in illiterate and literate patients.The effect of combination therapy of hyperbaric oxygen, meropenem, and selective nitric oxide synthase inhibitor in experimental acute pancreatitis.A comparison of end-stage renal disease and Alzheimer's disease in the elderly through a comprehensive geriatric assessment.Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.Ogilvie's syndrome in an elderly patient with multi-system atrophy.The relationship between age and carotid artery intima-media thickness, hemoglobin A1c in nondiabetic, healthy geriatric population.Allopurinol in rat chronic pancreatitis: effects on pancreatic stellate cell activation.Rat liver fibrosis regresses better with pegylated interferon alpha2b and ursodeoxycholic acid treatments than spontaneous recovery.Attended With and Head-Turning Sign can be clinical markers of cognitive impairment in older adults.Corrigendum to "Inflammation and frailty in the elderly: A systematic review and meta-analysis" [Ageing Res Rev. 31 (2016) 1-8].The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer's disease.Vitamin B12 deficiency might be related to sarcopenia in older adults.The Saint Louis University Mental Status Examination Is Better than the Mini-Mental State Examination to Determine the Cognitive Impairment in Turkish Elderly People.Comments on "Relationship between cardiac autonomic function and cognitive function in Alzheimer's disease".Triple test, a diagnostic observation, can detect cognitive impairment in older adults.Neuroleptic malignant syndrome associated with only one dose of metoclopramide in an older adult.Uric acid may be protective against cognitive impairment in older adults, but only in those without cardiovascular risk factors.Comment on "Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition".Neuroleptic malignant syndrome in an elderly patient with normal pressure hydrocephalus overlapping corticobasal degeneration.Effects of Acetylcholinesterase Inhibitors on Balance and Gait Functions and Orthostatic Hypotension in Elderly Patients With Alzheimer Disease.Asymptomatic Bradycardia Due to Rivastigmine in an Elderly Adult with Lewy Body Dementia.Mesenchymal stem cell therapy for the streptozotocin-induced neurodegeneration in rats.aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease.The relationship between body mass index and incidental mild cognitive impairment, Alzheimer's disease and vascular dementia in elderly.The evaluation and design of a short depression screening tool in Turkish older adults.Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
P50
Q24811564-4E1AFD59-A03B-4470-B01D-144EFDE93A05Q24811791-A072EABA-5951-44AF-A2E2-0191F836EB9EQ28072928-51A6D583-B340-4650-9090-09DF364C240BQ34225221-EADF8AD8-5B09-445D-9C48-603EF9485276Q35184676-F3A3C925-5F65-407D-A81D-B903F811E589Q37105066-444604B4-4B35-47D1-B0E5-DEA7A0237E60Q37616160-5F3BBE46-5898-494F-A592-310873E22227Q38736756-5553D8BA-6767-4928-866E-0F2B16E7BD6EQ38793364-33D8387A-0435-4815-993E-3B97F3C94271Q38853967-C2A90FF1-D34A-4AFC-98C8-DDB119DBE46BQ39851868-269D6905-AADA-4CB5-AFF6-2F98AC09A465Q39901937-55FF3691-4E62-4502-97E2-155BDB67A599Q42749917-2B8362CE-E9BB-45B1-9C33-5D6AC2C88A0DQ43638239-5F7BE8B2-9FD6-4E3F-B626-AF015AD7DA99Q43732682-A269F4E0-4423-4DD9-B2F1-FB314D1193E0Q44715470-5BF4EE3D-AA77-411A-9884-D87E0E063F9FQ44990368-072D4848-9FEB-4506-81CD-D86283432E60Q45920578-EF2A24EF-85C8-4A29-A24A-1E45C000437FQ46191806-DA3A25FB-13A4-4C4A-9DA8-9E18EFD4A2C5Q46638653-B83B6FA9-5D8A-4339-9DA8-87A090530D15Q46843173-6E34C1C1-546C-4E7D-9602-79FE4106C4E9Q46920611-2D6FE2A6-64DA-4B01-9952-B506140BF38AQ47681196-C7E492FE-5787-480D-9D7C-B6CB107C3570Q47827439-49FBA11A-B424-4DDB-972C-BBD312536795Q47836696-D28A8FB0-6E57-465D-9642-01E55B4AB665Q47874824-04C398C5-2161-49CE-9640-F91AEC5685F3Q47893455-18F4ADC2-8434-4E2B-8A03-5BA4D7C4176FQ47940782-CF80BD45-2ECA-423F-9226-16DCEB23DD31Q48096893-5FF83C84-D087-468C-ADF1-EA3E51E194E8Q48135925-07660AFF-9EAE-4CBE-8406-1A4F4B4A6C0BQ48368661-0BF25FFE-C216-4D6A-8016-62C165A0C536Q48493532-751CD475-7710-4FC7-9D8F-E359B134589AQ48498000-D8968C5E-4CC6-4554-8EFF-7394429F6138Q48536715-FFB6225C-9F68-4E71-B441-5124D3CDB33DQ49117490-5E7403B2-5DE9-4A7F-A166-C9BC32675F61Q50229788-CBB6A209-D802-436C-B3BF-427214A2E71FQ50769472-D77A6DFA-C06A-4293-A99E-4B267AF01F5BQ51740907-345341A1-D8FF-477D-A1F0-DE6C472BBC13Q51761027-C37D0023-C714-4D38-A3D2-CDF22DAD558EQ52721046-0EA03FA1-7F8C-486C-8007-31526D6486EC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ahmet Turan Isik
@ast
Ahmet Turan Isik
@en
Ahmet Turan Isik
@es
Ahmet Turan Isik
@nl
type
label
Ahmet Turan Isik
@ast
Ahmet Turan Isik
@en
Ahmet Turan Isik
@es
Ahmet Turan Isik
@nl
prefLabel
Ahmet Turan Isik
@ast
Ahmet Turan Isik
@en
Ahmet Turan Isik
@es
Ahmet Turan Isik
@nl
P106
P1153
7003332861
P21
P31
P496
0000-0001-5867-6503